SCHEMBL7205487

SCHEMBL7205487

C#CC(O)c1ccc(OC(F)(F)F)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.42
ALDH1A1 P00352 3/20 0.42
MAPT P10636 3/20 0.41
EPHX2 P34913 2/20 0.41
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
TP53 P04637 1/20 0.38
CYP3A4 P08684 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
BLM P54132 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HIF1A Q16665 1/20 0.38
HSD17B10 Q99714 1/20 0.38
EPAS1 Q99814 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
TOP2A P11388 1/20 0.38
TOP2B Q02880 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL646362 0.78 TOP2A (0.49) PDE2AALDH1A1MAPTEPHX2KMT2A
SCHEMBL16771224 0.78 PDE2A (0.49) PDE2AALDH1A1MAPTEPHX2KMT2A
SCHEMBL28186043 0.78 PDE2A (0.42) PDE2AALDH1A1MAPTEPHX2KMT2A
SCHEMBL7202728 0.77 CYP2C9 (0.50) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL29184903 0.77 ESR1 (0.46) TSHR
SCHEMBL7200546 0.76 ALOX15 (0.41) ALDH1A1MAPTKMT2AMEN1ALOX15
SCHEMBL31135330 0.75 PDE2A (0.40) PDE2AMAPTGPR3
SCHEMBL6168264 0.75 CA1 (0.46) ALDH1A1MAPTTSHRTDP1L3MBTL1
SCHEMBL18291828 0.75 PDE2A (0.54) PDE2AALDH1A1MAPTEPHX2TOP2A
SCHEMBL1759620 0.75 PDE2A (0.46) PDE2AALDH1A1MAPTEPHX2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024222614-A1 HETEROCYCLIC GSPT1 DEGRADATION AGENT 北京诺诚健华医药科技有限公司 2024-10-31 WO disclosed
US-6605730-B2 3-(2-Thienyl)-5-phenyl-1H-pyrazole compounds of given formula NIHON BAYER AGROCHEM K.K. (JP) 2003-08-12 US disclosed
US-20030028034-A1 Nematicidal pyrazoles WADA KATSUAKI (JP) 2003-02-06 US disclosed
US-6310049-B1 3-(2-THIENYL),5-(SUBSTITUTED PHENYL)-1H-PYRAZOLES AND 3-(SUBSTITUTED PHENYL),5-(2-THIENYL)-1H-PYRAZOLES OF GIVEN FORMULA; ANTHELMINTICS NIHON BAYER AGROCHEM K.K. (JP) 2001-10-30 US disclosed
EP-1104418-A2 NEMATICIDAL PYRAZOLES NIHON BAYER AGROCHEM K.K. (JP) 2001-06-06 EP disclosed
WO-2000009500-A2 NEMATICIDAL PYRAZOLES NIHON BAYER AGROCHEM K.K. (JP) 2000-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030028034-A1 Nematicidal pyrazoles CBR3, CBR1, CCR4 PDE2A 3419/4885ALDH1A1 1476/4885MAPT 4683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.